This workshop offers a comprehensive deep dive into the rapidly evolving field of radiopharmaceuticals. The agenda spans the full development lifecycle, beginning with a high-level view of the market landscape, deal-making trends, and future directions in oncology and beyond. Expert sessions will tackle critical technical hurdles, including CMC challenges, theranostic development, and manufacturing for first-in-human trials. Attendees will also gain insights into clinical strategies, such as dose selection and PET imaging agents, alongside essential legal considerations regarding IP strategy.